CompletedPhase 3NCT02644941

Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis

Studying Complication in hemodialysis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Humacyte, Inc.
Principal Investigator
Shamik Parikh, MD
Humacyte, Inc.
Intervention
Human Acellular Vessel (HAV)(biological)
Enrollment
355 enrolled
Eligibility
18 years · All sexes
Timeline
20162023

Study locations (30)

Collaborators

CTI Clinical Trial and Consulting Services · California Institute for Regenerative Medicine (CIRM)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02644941 on ClinicalTrials.gov

Other trials for Complication in hemodialysis

Additional recruiting or active studies for the same condition.

See all trials for Complication in hemodialysis

← Back to all trials